Sonendo, Inc (SONX) Fair Value & Analysis
Healthcare · US · Market cap $2.9M
Sonendo, Inc
SONX · US
Fair value as of: Jul 18, 2026
From 1 valuation models · updated today
Fair value updated Jul 18, 2026, revised from $4.90 to $0.3600 (−92.7%) since Jun 24, 2026. Share price +36.7% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0200 – $1.15 · fair‑value band $0.2400 – $0.4500 · the $0.8200 price screens above the $0.3600 fair value. As of Jul 18, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sonendo, Inc (SONX) currently trades at $0.8200, while our model-based Fair Value estimate is $0.3600, implying the stock looks roughly 56.1% overvalued today. We read business quality at 37/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, Sonendo, Inc generated revenue of $31.7M at a net margin of -88.4%. Revenue declined 29.0% year over year. Net debt stands at $8.7M. Fundamentals as of Jul 18, 2026
Our scenario range runs from $0.2400 (bear case) to $0.4500 (bull case); at $0.8200, the current price sits above that range. The share trades about 29% below its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -23% fair-value upside, at -56%, SONX screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.
About the company
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
Sonendo, Inc reported revenue of $31.7M in FY2024 versus $23.4M in FY2020, a compound +7.9%/yr. Reported net income was −$28.0M in FY2024.
Is SONX fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | 1,600 MXN | 1,231 MXN | -23% |
| Stryker Corporation SYK | $308.84 | $187.83 | -39% |
| Medtronic plc MDTC34 | R$211.05 | R$29.52 | -86% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EWL | €74.82 | €32.56 | -56% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
| DexCom, Inc DXCM | $74.77 | $53.93 | -28% |
| GE HealthCare Technologies Inc GEHC | $60.64 | $65.03 | +7% |
| Koninklijke Philips N.V 1PHIA | €24.31 | €9.97 | -59% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sonendo, Inc (SONX) undervalued?
What is the fair value of SONX?
What is the quality score of SONX?
What is the revenue of Sonendo, Inc (SONX)?
What is the net profit margin of SONX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when Sonendo, Inc reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of Sonendo, Inc materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.